特刊"乳腺癌分子研究:病理生理学和治疗"
1Department of Cell and Cancer Biology, University of Toledo College of Medicine and Life Sciences, 3000 Arlington Avenue, Toledo, OH 43614, USA.
International journal of molecular sciences
|October 16, 2025
概括
乳腺癌是全球主要的健康挑战,尤其对女性来说. 进一步的研究对于开发有效的乳腺癌治疗方法和改善全球患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 妇女健康 妇女健康
- 癌症研究 癌症研究
背景情况:
- 乳腺癌是全球女性最常见的癌症诊断.
- 它代表了全球癌症相关死亡的重要原因.
- 在乳腺癌的诊断和治疗方面不断需要进步.
研究的目的:
- 为了研究乳腺癌的新型治疗点.
- 探索用于早期检测的创新诊断策略.
- 为了提高对乳腺癌分子机制的理解.
主要方法:
- 使用先进的基因组测序技术.
- 使用复杂的生物信息学分析.
- 使用新药候选药物进行临床前研究.
主要成果:
- 确定一个有前途的新治疗点.
- 验证一种用于早期检测的新生物标志物.
- 在临床前模型中证明了显著的瘤生长抑制.
结论:
- 这些发现为乳腺癌治疗提供了潜在的突破.
- 早期检测生物标志物可以显著提高患者的生存率.
- 持续的研究对于将这些发现转化为临床实践至关重要.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


